Shares in Qiagen hit a 52-week high of $15.58 earlier this week before closing at $14.91 on Tuesday, up 8.4 percent for the tracking period. Shares in Qiagen, which led gains among all issues in the BCW Index, have risen 32.5 percent over the past month.

Meanwhile, Bio-Rad shares dropped 11.9 percent for the week, leading all decliners. Last week, the firm reported that its fourth-quarter profit and revenue were hit by costs associated with a legal dispute (see feature).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.